Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide

被引：0
|
作者：
Nikki McCaffrey
Tegan Asser
Belinda Fazekas
Wendy Muircroft
Meera Agar
Katherine Clark
Simon Eckermann
Jessica Lee
Rohit Joshi
Peter Allcroft
Caitlin Sheehan
David C. Currow
机构：
[1] Deakin University,Deakin Health Economics, Centre for Population Health Research, School of Health and Social Development
[2] Flinders University,Palliative & Supportive Services
[3] Flinders University,School of Medicine
[4] University of Technology,IMPACCT, Faculty of Health
[5] University of Technology Sydney,Australian National Cancer Symptom Trials Group
[6] Southern Adelaide Local Health Network,Southern Adelaide Palliative Services
[7] Liverpool Hospital,Cancer & Palliative Care Network
[8] South West Sydney Local Health District,Northern Clinical School
[9] Northern Sydney Local Health District,Centre for Health Service Development
[10] The University of Sydney,Concord Centre for Palliative Care
[11] Australian Health Services Research Institute,Medical Oncology
[12] University of Wollongong,Wolfson Palliative Care Research Centre
[13] Concord Repatriation General Hospital,undefined
[14] Lyell McEwin Hospital,undefined
[15] Calvary Heath Care,undefined
[16] University of Hull,undefined
来源：
BMC Cancer | / 20卷
关键词：
Patient-reported outcome measures; Neoplasms; Intestinal obstruction; Terminal care; Palliative care; Randomised controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide
    McCaffrey, Nikki
    Asser, Tegan
    Fazekas, Belinda
    Muircroft, Wendy
    Agar, Meera
    Clark, Katherine
    Eckermann, Simon
    Lee, Jessica
    Joshi, Rohit
    Allcroft, Peter
    Sheehan, Caitlin
    Currow, David C.
    BMC CANCER, 2020, 20 (01)
  • [2] Double-Blind, Placebo-Controlled, Randomized Trial of Octreotide in Malignant Bowel Obstruction
    Currow, David C.
    Quinn, Stephen
    Agar, Meera
    Fazekas, Belinda
    Hardy, Janet
    McCaffrey, Nikki
    Eckermann, Simon
    Abernethy, Amy P.
    Clark, Katherine
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (05) : 814 - 821
  • [3] Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
    Sanyal, A.
    Younossi, Z. M.
    Bass, N. M.
    Mullen, K. D.
    Poordad, F.
    Brown, R. S.
    Vemuru, R. P.
    Jamal, M. Mazen
    Huang, S.
    Merchant, K.
    Bortey, E.
    Forbes, W. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 853 - 861
  • [4] Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial
    Nouri-Vaskeh, Masoud
    Afshan, Hossein
    Mahdavi, Aida Malek
    Alizadeh, Leila
    Fan, Xiude
    Zarei, Mohammad
    COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49
  • [5] IMPACT OF INOTERSEN ON GENERIC HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH HATTR AMYLOIDOSIS: RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Yarlas, A.
    Kessler, Sikora A.
    Lovley, A.
    Guthrie, S.
    Pollock, M.
    White, M. K.
    VALUE IN HEALTH, 2018, 21 : S354 - S354
  • [6] Health-related quality of life (HRQOL) and disability in chronic migraine: Results from a randomized, double-blind, placebo-controlled trial of topiramate
    Dodick, David
    Silberstein, Stephen
    Saper, Joel
    Mathew, Ninan
    Hulihan, Joseph
    Crivera, Concetta
    Rupnow, Marcia
    Mao, Lion
    Greenberg, Steven
    NEUROLOGY, 2007, 68 (12) : A370 - A370
  • [7] HOMOCYSTEINE AND MENTAL HEALTH IN OLDER PATIENTS: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Gariballa, S. E.
    AGE AND AGEING, 2011, 40 : II11 - II11
  • [8] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Shiina, Akihiro
    Shirayama, Yukihiko
    Niitsu, Tomihisa
    Hashimoto, Tasuku
    Yoshida, Taisuke
    Hasegawa, Tadashi
    Haraguchi, Tadashi
    Kanahara, Nobuhisa
    Shiraishi, Tetsuya
    Fujisaki, Mihisa
    Fukami, Goro
    Nakazato, Michiko
    Iyo, Masaomi
    Hashimoto, Kenji
    ANNALS OF GENERAL PSYCHIATRY, 2010, 9
  • [9] A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
    Akihiro Shiina
    Yukihiko Shirayama
    Tomihisa Niitsu
    Tasuku Hashimoto
    Taisuke Yoshida
    Tadashi Hasegawa
    Tadashi Haraguchi
    Nobuhisa Kanahara
    Tetsuya Shiraishi
    Mihisa Fujisaki
    Goro Fukami
    Michiko Nakazato
    Masaomi Iyo
    Kenji Hashimoto
    Annals of General Psychiatry, 9
  • [10] Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial
    Seddighnia, Azadeh
    Najafabadi, Borna Tadayon
    Ghamari, Kiandokht
    Noorbala, Ahmad Ali
    Daryani, Naser Ebrahimi
    Kashani, Ladan
    Akhondzadeh, Shahin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (01) : 97 - 104
12345